234 related articles for article (PubMed ID: 27913496)
1. Discussing and managing hematologic germ line variants.
Kohlmann W; Schiffman JD
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
[TBL] [Abstract][Full Text] [Related]
2. Discussing and managing hematologic germ line variants.
Kohlmann W; Schiffman JD
Blood; 2016 Nov; 128(21):2497-2503. PubMed ID: 27881370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
4. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
5. Predisposition to pediatric and hematologic cancers: a moving target.
Malkin D; Nichols KE; Zelley K; Schiffman JD
Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
[TBL] [Abstract][Full Text] [Related]
6. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
7. Germ line mutations associated with leukemias.
Porter CC
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):302-308. PubMed ID: 27913495
[TBL] [Abstract][Full Text] [Related]
8. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
[TBL] [Abstract][Full Text] [Related]
9. Heritability of hematologic malignancies: from pedigrees to genomics.
Churpek JE; Onel K
Hematol Oncol Clin North Am; 2010 Oct; 24(5):939-72. PubMed ID: 20816581
[TBL] [Abstract][Full Text] [Related]
10. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
11. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
12. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
13. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
14. Introduction to cancer genetic susceptibility syndromes.
McGee RB; Nichols KE
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):293-301. PubMed ID: 27913494
[TBL] [Abstract][Full Text] [Related]
15. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
16. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
[TBL] [Abstract][Full Text] [Related]
17. Recognition of familial myeloid neoplasia in adults.
Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
[TBL] [Abstract][Full Text] [Related]
18. Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation.
Garg K; Karnezis AN; Rabban JT
Pathology; 2018 Feb; 50(2):238-256. PubMed ID: 29373116
[TBL] [Abstract][Full Text] [Related]
19. How I diagnose and manage individuals at risk for inherited myeloid malignancies.
University of Chicago Hematopoietic Malignancies Cancer Risk Team
Blood; 2016 Oct; 128(14):1800-1813. PubMed ID: 27471235
[TBL] [Abstract][Full Text] [Related]
20. Practical considerations for diagnosis and management of patients and carriers.
Niemeyer CM; Mecucci C
Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]